A
Aria CV
Developing a medical device designed to improve the lives of patients living with the disease of Pulmonary Arterial Hypertension
About Aria CV
Aria CV is a medical device company focused on developing a novel implantable device designed to treat pulmonary hypertension (PH). The company's core product is an elegant device that operates without batteries, pumps, or electronics, relying entirely on the motion of the heart. This device consists of four simple components: a reservoir, a balloon, a narrow conduit allowing gas movement, and a nitinol anchor that holds the balloon in place. Aria CV primarily serves patients suffering from pulmonary hypertension, a condition characterized by high blood pressure in the lungs' arteries, which can lead to heart failure if untreated. The company operates in the medical device market, targeting healthcare providers and institutions involved in treating PH. Aria CV's business model revolves around clinical trials and investigational use, aiming to gain regulatory approval for widespread adoption. Revenue generation is expected through the commercialization of the device post-approval, focusing on partnerships with healthcare providers and direct sales to medical institutions.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2010
- Headquarters
- Plymouth, United States
- Employees
- 10
- Open positions
- None listed
- Dealroom signal
- 64.6/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, medical implants, Chronic Disease, Pulmonary, Spinout, Disease, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Jul 2022 | $13M | $155M | Undisclosed | ↗ |
| SERIES BOther financing | Feb 2020 | $31M | $124M | Catalyst Health Ventures · Longview Ventures · BioStar Capital · Cedar Point Capital | ↗ |
Growth signals
Latest recorded traffic for Aria CV is 730 monthly website visits, down 15.1% over the last three months. Aria CV's team declined 28.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
- CVCatalyst Health Ventures
Broadview Ventures
BioStar Capital
Xeraya Capital
Longview Ventures
Cedar Point Capital
Other known investors1 additional known investor
University of Minnesota Twin Cities
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Aria CV on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Aria CV’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.